Coordinating the Global Introduction of Sino-implant (II)

October 10, 2010 • Family Planning, Reproductive Health, Daily Email Recap

Thanks to Erik Bergstrom for this information.

The contraceptive implant is a highly effective, safe, long-acting, and popular contraceptive method that has been shown to be acceptable to women worldwide. However, the high cost of this commodity has been a major barrier to its availability in many countries. Sino-implant (II) addresses this problem. As of 2009, this implant cost about 60 percent less than others available, according to the Reproductive Health Supplies Coalition database. Under a current five-year grant awarded to FHI by the Bill & Melinda Gates Foundation, FHI facilitates the safe and sustainable introduction of Sino-implant (II) in resource-constrained countries. Sino-implant (II)-marketed as Zarin, as Femplant, and under other trade names-is composed of two thin rods, each containing 75 mg of levonorgestrel, the active ingredient. Sino-implant (II) is comparable to Jadelle, in that it provides the same amount of levonorgestrel and has the same mechanism of action. It is currently labeled for four years of use and is distributed with a CE-marked disposable trocar.

For full article, visit:

Current World Population


Net Growth During Your Visit